Open AccessRethinking clinical oncology drug research in an era of value‐based cancer care: A role for chemotherapy pathways
Author(s) -
Hoverman J. Russell
Publication year - 2020
Publication title -
cancer medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.403
H-Index - 53
ISSN - 2045-7634
DOI - 10.1002/cam4.3193
Subject(s) - clinical oncology , value (mathematics) , health care , medicine , chemotherapy , oncology , cancer treatment , cancer drugs , drug development , cancer , drug , intensive care medicine , cancer chemotherapy , economic growth , pharmacology , computer science , economics , machine learning
The United States spends nearly 1/5th of its GDP on healthcare. Yet, to achieve value‐based care, the Economist describes the US healthcare system as handicapped by multiple, disparate silos that prevent the organization and sharing of data. This paper explores the current state of clinical oncology drug research and its relationship to value‐based cancer care. Clinical Chemotherapy Pathways are proposed as a unifying structure to bring together disparate sources of data to increase value.